193 related articles for article (PubMed ID: 19691429)
1. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
3. Production of human parvovirus 4 VP2 virus-like particles in yeast and their evaluation as an antigen for detection of virus-specific antibodies in human serum.
Tamošiūnas PL; Simutis K; Kodzė I; Firantienė R; Emužytė R; Petraitytė-Burneikienė R; Zvirblienė A; Sasnauskas K
Intervirology; 2013; 56(5):271-7. PubMed ID: 23941824
[TBL] [Abstract][Full Text] [Related]
4. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
Manning A; Willey SJ; Bell JE; Simmonds P
J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
[TBL] [Abstract][Full Text] [Related]
5. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates.
Sharp CP; Lail A; Donfield S; Gomperts ED; Simmonds P
Transfusion; 2012 Jul; 52(7):1482-9. PubMed ID: 22043925
[TBL] [Abstract][Full Text] [Related]
6. Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.
Sharp CP; LeBreton M; Kantola K; Nana A; Diffo Jle D; Djoko CF; Tamoufe U; Kiyang JA; Babila TG; Ngole EM; Pybus OG; Delwart E; Delaporte E; Peeters M; Soderlund-Venermo M; Hedman K; Wolfe ND; Simmonds P
J Virol; 2010 Oct; 84(19):10289-96. PubMed ID: 20668071
[TBL] [Abstract][Full Text] [Related]
7. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.
Simmons R; Sharp C; Sims S; Kloverpris H; Goulder P; Simmonds P; Bowness P; Klenerman P
J Infect Dis; 2011 May; 203(10):1378-87. PubMed ID: 21502079
[TBL] [Abstract][Full Text] [Related]
8. Antigenicity study of the yeast-generated human parvovirus 4 (PARV4) virus-like particles.
Lazutka J; Simutis K; Matulis P; Petraitytė-Burneikienė R; Kučinskaitė-Kodzė I; Simanavičius M; Tamošiunas PL
Virus Res; 2021 Jan; 292():198236. PubMed ID: 33242523
[TBL] [Abstract][Full Text] [Related]
9. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus 4 infection and clinical outcome in high-risk populations.
Simmons R; Sharp C; McClure CP; Rohrbach J; Kovari H; Frangou E; Simmonds P; Irving W; Rauch A; Bowness P; Klenerman P;
J Infect Dis; 2012 Jun; 205(12):1816-20. PubMed ID: 22492853
[TBL] [Abstract][Full Text] [Related]
11. Human parvovirus PARV4 in clotting factor VIII concentrates.
Fryer JF; Hubbard AR; Baylis SA
Vox Sang; 2007 Nov; 93(4):341-7. PubMed ID: 18070279
[TBL] [Abstract][Full Text] [Related]
12. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of human herpesvirus type 8 and parvovirus B19 infections and their association with HIV-1 among men who have sex with men and injection drug users in Taiwan.
Lee YM; Chuang SY; Wang SF; Lin YT; Chen YM
J Microbiol Immunol Infect; 2014 Jun; 47(3):233-8. PubMed ID: 23465711
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of human bocaviruses and parvovirus 4 in solid tissues.
Norja P; Hedman L; Kantola K; Kemppainen K; Suvilehto J; Pitkäranta A; Aaltonen LM; Seppänen M; Hedman K; Söderlund-Venermo M
J Med Virol; 2012 Aug; 84(8):1267-73. PubMed ID: 22711355
[TBL] [Abstract][Full Text] [Related]
15. A third genotype of the human parvovirus PARV4 in sub-Saharan Africa.
Simmonds P; Douglas J; Bestetti G; Longhi E; Antinori S; Parravicini C; Corbellino M
J Gen Virol; 2008 Sep; 89(Pt 9):2299-2302. PubMed ID: 18753240
[TBL] [Abstract][Full Text] [Related]
16. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of antibody to parvovirus B19 in hemophiliacs and in the general population.
Eis-Hübinger AM; Oldenburg J; Brackmann HH; Matz B; Schneweis KE
Zentralbl Bakteriol; 1996 Jul; 284(2-3):232-40. PubMed ID: 8837383
[TBL] [Abstract][Full Text] [Related]
18. Parenteral transmission of the novel human parvovirus PARV4.
Simmonds P; Manning A; Kenneil R; Carnie FW; Bell JE
Emerg Infect Dis; 2007 Sep; 13(9):1386-8. PubMed ID: 18252117
[TBL] [Abstract][Full Text] [Related]
19. Evolution of CD8+ T cell responses after acute PARV4 infection.
Simmons R; Sharp C; Levine J; Bowness P; Simmonds P; Cox A; Klenerman P
J Virol; 2013 Mar; 87(6):3087-96. PubMed ID: 23283958
[TBL] [Abstract][Full Text] [Related]
20. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
